Drug
Las41008
Las41008: highest development phase Phase 3, developed by Almirall. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Almirall
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAS41008 NCT01726933 | Phase 3 | Plaque Psoriasis |
Latest
No recent events.
Follow Las41008 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.